Institutions / Sio Capital Management, LLC
Sio Capital Management, LLC
CIK 1482416 · Institution · as of Dec 31, 2025
Portfolio value
$603.16M
Positions
65
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 65 →
| Company | Value | % of portfolio |
|---|---|---|
| Celcuity Inc.CELC | $47.58M | 7.9% |
| Cigna Group | $47.40M | 7.9% |
| Sanofi | $47.09M | 7.8% |
| Maximus Inc | $43.19M | 7.2% |
| Zimmer Biomet Holdings Inc | $34.68M | 5.7% |
| Kenvue Inc. | $25.28M | 4.2% |
| Organon & Co. | $24.53M | 4.1% |
| ICON plc | $23.18M | 3.8% |
| Waystar Holding Corp. | $20.10M | 3.3% |
| LivaNova PLC | $19.84M | 3.3% |
| Dianthus Therapeutics, Inc. | $19.55M | 3.2% |
| Biohaven Ltd. | $14.05M | 2.3% |
| Structure Therapeutics Inc.GPCR | $14.01M | 2.3% |
| BioMarin Pharmaceutical Inc | $13.83M | 2.3% |
| Tyra Biosciences, Inc. | $13.83M | 2.3% |
| BrightSpring Health Services, Inc. | $11.53M | 1.9% |
| Centene Corp | $11.29M | 1.9% |
| Charles River Labs Intl Inc | $10.97M | 1.8% |
| Teleflex Inc | $10.60M | 1.8% |
| Anteris Technologies Global Corp. | $9.35M | 1.6% |
| Protara Therapeutics, Inc. | $9.14M | 1.5% |
| Cross Country Healthcare Inc | $8.66M | 1.4% |
| Haemonetics Corporation | $7.42M | 1.2% |
| Ani Pharmaceuticals Inc | $6.89M | 1.1% |
| Aquestive Therapeutics, Inc.AQST | $6.42M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.